4//SEC Filing
Resnick Joshua 4
Accession 0001610618-25-000006
CIK 0001610618other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 6:38 PM ET
Size
6.1 KB
Accession
0001610618-25-000006
Insider Transaction Report
Form 4
Resnick Joshua
Director
Transactions
- Award
Stock Option (right to buy)
2025-01-03+22,200→ 22,200 totalExercise: $26.62Exp: 2035-01-02→ Common Stock (22,200 underlying)
Footnotes (2)
- [F1]1/3rd of the total number of shares subject to the award shall vest on January 3, 2026 and the remaining 2/3rds of the shares will vest in equal monthly installments over the following two year period such that the option is fully vested on January 3, 2028.
- [F2]Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the option for the benefit of the RA Capital Healthcare Fund, L.P. (the "Fund"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option, which will offset advisory fees owed by the Fund to the Adviser. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock.
Documents
Issuer
Cidara Therapeutics, Inc.
CIK 0001610618
Entity typeother
Related Parties
1- filerCIK 0001690959
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 6:38 PM ET
- Size
- 6.1 KB